Search results for "fagiterapia"

showing 10 items of 20 documents

The forgotten tale of Brazilian phage therapy

2020

The use of bacteriophages to treat bacterial infections (known as phage therapy) is considered a possible solution to the antimicrobial resistance crisis. However, phage therapy is not a new concept. The discovery of phages in the early 20th century was closely tied to clinical practice, and phage therapy quickly spread around the world. The use of phage therapy in South America in the previous century is still shrouded in mystery and has been mentioned only briefly in recent scientific literature. Research on Brazilian reference collections of medical texts showed that Brazil was an important, but so far little-known, player of phage therapy, uncovering interesting priority claims and miss…

0301 basic medicinemedicine.medical_specialtybacteriophagesphage therapybakteeritauditHistoryPhage therapyvirusesmedicine.medical_treatment030106 microbiologyStaphylococcal infectionsbakteriofagit03 medical and health sciencesAntibiotic resistanceoppihistoriamedicineHumansBacteriophagesPhage TherapytutkimushistoriaBacillary dysenteryBacterial Infectionsmedicine.diseasefagiterapiaClinical Practice030104 developmental biologyInfectious Diseasesbacterial infectionsFamily medicineBrasiliaBrazilThe Lancet Infectious Diseases
researchProduct

The Fate of Bacteriophages in Recirculating Aquaculture Systems (RAS)—Towards Developing Phage Therapy for RAS

2019

Aquaculture production has increased tremendously during the last decades, and new techniques have been developed, e.g., recirculating aquaculture systems (RAS). In RAS, the majority of water volume is circulated via mechanical and biological filters and reused in the tanks. However, the prevention and treatment of diseases in these systems are challenging, as the pathogens spread throughout the system, and the addition of chemicals and antibiotics disrupts the microbiome of the biofilters. The increasing antibiotic resistance has made phage therapy a relevant alternative for antibiotics in food production. Indeed, as host-specific and self-replicating agent they might be optimal for target…

11832 Microbiology and virologydiseasephage therapylcsh:RM1-950virusbiofilterkalatauditArticlebakteriofagitfagiterapialcsh:Therapeutics. Pharmacologyaquaculturebacteriophage1182 Biochemistry cell and molecular biologyrecirculating aquaculture systemsvesiviljely (kalatalous)RASAntibiotics
researchProduct

Targeting antibiotic resistant bacteria with phage reduces bacterial density in an insect host

2019

Phage therapy is attracting growing interest among clinicians as antibiotic resistance continues becoming harder to control. However, clinical trials and animal model studies on bacteriophage treatment are still scarce and results on the efficacy vary. Recent research suggests that using traditional antimicrobials in concert with phage could have desirable synergistic effects that hinder the evolution of resistance. Here, we present a novel insect gut model to study phage–antibiotic interaction in a system where antibiotic resistance initially exists in very low frequency and phage specifically targets the resistance bearing cells. We demonstrate that while phage therapy could not reduce th…

Insectaantibiotic resistancephage therapyPhage therapymedicine.drug_classmedicine.medical_treatmentAntibioticsPopulationGut florabakteriofagitMicrobiologyBacteriophage03 medical and health sciencesAntibiotic resistanceinsect modelbacteriophageEnterobacter cloacaemedicineenterobakteeritgut infectionAnimalsBacteriophageseducation030304 developmental biologyEvolutionary Biology0303 health scienceseducation.field_of_studyBacteriabiology030306 microbiologyta1182biology.organism_classificationAntimicrobialAgricultural and Biological Sciences (miscellaneous)Anti-Bacterial AgentsfagiterapiaGeneral Agricultural and Biological SciencesBacteriaantibioottiresistenssiBiology Letters
researchProduct

Comparison of Delivery Methods in Phage Therapy against Flavobacterium columnare Infections in Rainbow Trout

2021

Viruses of bacteria, bacteriophages, specifically infect their bacterial hosts with minimal effects on the surrounding microbiota. They have the potential to be used in the prevention and treatment of bacterial infections, including in the field of food production. In aquaculture settings, disease-causing bacteria are often transmitted through the water body, providing several applications for phage-based targeting of pathogens, in the rearing environment, and in the fish. We tested delivery of phages by different methods (via baths, in phage-coated material, and via oral delivery in feed) to prevent and treat Flavobacterium columnare infections in rainbow trout fry using three phages (FCOV…

Microbiology (medical)Microbiological culturebakteeritauditphage therapyPhage therapymedicine.medical_treatmentVirulenceRM1-950BiologyBiochemistryMicrobiologyArticlebakteriofagitMicrobiologybakteeritBacteriophage03 medical and health sciencesFlavobacterium columnareAquaculturebacteriophagehoitomenetelmätmedicinePharmacology (medical)General Pharmacology Toxicology and Pharmaceuticsvesiviljely (kalatalous)030304 developmental biology0303 health sciencestreatment030306 microbiologybusiness.industrylohikalatbacterial infectionbiology.organism_classification<i>Flavobacterium columnare</i>rainbow trout3. Good healthfagiterapiavirulenceInfectious Diseasesphage deliveryaquaculturecolumnaris diseaseFlavobacterium columnareRainbow troutTherapeutics. PharmacologybusinessBacteriaAntibiotics
researchProduct

On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy

2015

Bacteriophages are bacterial viruses, capable of killing even multi-drug resistant bacterial cells. For this reason, therapeutic use of phages is considered as a possible alternative to conventional antibiotics. However, phages are very host specific in comparison to wide-spectrum antibiotics and thus preparation of phage-cocktails beforehand against pathogens can be difficult. In this study, we evaluate whether it may be possible to isolate phages on-demand from environmental reservoir. We attempted to enrich infectious bacteriophages from sewage against nosocomial drug-resistant bacterial strains of different medically important species in order to evaluate the probability of discovering …

Microbiology (medical)Phage cocktailsantibiotic resistancephage therapyPhage therapyKlebsiella pneumoniaevirusesmedicine.medical_treatmentlcsh:QR1-502MRSABiologyta3111medicine.disease_causeMicrobiologybakteriofagitlcsh:MicrobiologyMicrobiologyAntibiotic resistancephage cocktailsmedicineBacteriophagesVancomycin-resistant EnterococcusOriginal ResearchPseudomonas aeruginosata1183biology.organism_classificationVirologyMethicillin-resistant Staphylococcus aureusfagiterapia3. Good healthAcinetobacter baumanniiESBLBacterial virusantibioottiresistenssiFrontiers in Microbiology
researchProduct

Adapting a Phage to Combat Phage Resistance

2020

Phage therapy is becoming a widely recognized alternative for fighting pathogenic bacteria due to increasing antibiotic resistance problems. However, one of the common concerns related to the use of phages is the evolution of bacterial resistance against the phages, putatively disabling the treatment. Experimental adaptation of the phage (phage training) to infect a resistant host has been used to combat this problem. Yet, there is very little information on the trade-offs of phage infectivity and host range. Here we co-cultured a myophage FCV-1 with its host, the fish pathogen Flavobacterium columnare, in lake water and monitored the interaction for a one-month period. Phage resistance was…

Microbiology (medical)phage therapyGLIDING MOTILITYPhage therapyvirusesmedicine.medical_treatmentevoluutioVirulencefish pathogenmedicine.disease_causeBiochemistryMicrobiologyGenomebakteriofagitArticleMicrobiologyBacteriophage03 medical and health sciencesAntibiotic resistancemedicineCRISPRPharmacology (medical)General Pharmacology Toxicology and Pharmaceutics030304 developmental biology11832 Microbiology and virologyInfectivitylääkeresistenssi0303 health sciencesPREDATIONPRODUCTIVITYbiology030306 microbiologylcsh:RM1-950ARMS-RACEPathogenic bacteriakalatauditbiology.organism_classificationEVOLUTIONfagiterapialcsh:Therapeutics. PharmacologyInfectious Diseasesphage resistancecoevolution1182 Biochemistry cell and molecular biologyVIRULENCEHOST-RANGEBACTERIOPHAGEAntibiotics
researchProduct

Outside-host phage therapy as a biological control against environmental infectious diseases

2018

Background Environmentally growing pathogens present an increasing threat for human health, wildlife and food production. Treating the hosts with antibiotics or parasitic bacteriophages fail to eliminate diseases that grow also in the outside-host environment. However, bacteriophages could be utilized to suppress the pathogen population sizes in the outside-host environment in order to prevent disease outbreaks. Here, we introduce a novel epidemiological model to assess how the phage infections of the bacterial pathogens affect epidemiological dynamics of the environmentally growing pathogens. We assess whether the phage therapy in the outside-host environment could be utilized as a biologi…

SI model0301 basic medicinevirusesmedicine.medical_treatmentVIBRIO-CHOLERAEDIVERSITYBacteriophageColumnaris diseasebacteriophageBacteriophageslcsh:QH301-705.5PathogenPOPULATION2. Zero hungerInfectivityeducation.field_of_studyPREDATIONEnvironmental opportunistCHANNEL CATFISHEVOLUTIONARY DYNAMICShost-parasite interactionflavobacteriumModeling and Simulationlcsh:R858-859.7biologinen torjuntaPhage therapy030106 microbiologyPopulationenvironmental opportunistVirulenceHealth InformaticsBiologylcsh:Computer applications to medicine. Medical informaticsinfektiotCommunicable DiseasesFlavobacteriumbakteriofagit03 medical and health sciencesmedicineAnimalsHumansPhage TherapyHost-parasite interactionBacteriophageeducationMORTALITYResearchFLAVOBACTERIUM-COLUMNAREOutbreakEnvironmental Exposurekalatauditbiology.organism_classificationVirologyfagiterapia030104 developmental biologylcsh:Biology (General)Infectious disease (medical specialty)BACTERIOPHAGE THERAPYVIRULENCE1182 Biochemistry cell and molecular biologyTheoretical Biology and Medical Modelling
researchProduct

Small things matter : of phages and antibiotic resistance conferring plasmids

2016

Viruses and plasmids are small units of genetic material dependent on cells either transiently or continuously. Intriguingly, stories of these small entities intertwine in antibiotic resistance crisis. Horizontal gene transfer enables bacteria to respond rapidly to chances in their environment. Anthropogenic consumption of antibiotics induces the travel of resistance encoding genes mainly as passengers of conjugative plasmids. In this thesis, I demonstrate that clinically important resistance plasmids could evolutionarily rescue susceptible bacteria under lethal antibiotic concentrations. If mobile resistance genes are available in surrounding community, administration of high doses of anti…

lääkeresistenssiantibiotic resistancephage therapygeenitviruksetantibiootitgeenitekniikkaprotein interactionsbakteriofagitfagiterapiabakteeritplasmiditfaagiterapiabacteriophageconjugative plasmidhorizontal gene transferproteiinithorisontaalinen geeninsiirto
researchProduct

Counteracting the horizontal spread of bacterial antibiotic resistance with conjugative plasmid-dependent bacteriophages

2016

lääkeresistenssiantibiotic resistancephage therapyplasmid-dependent phagesgeenitconjugative plasmidsantibiootitgeenitekniikkabakteriofagitfagiterapiabakteeritplasmiditfaagiterapiakonjugaatiohorizontal gene transferhorisontaalinen geeninsiirtoleviäminen
researchProduct

Microencapsulation of Enteric Bacteriophages in a pH-Responsive Solid Oral Dosage Formulation Using a Scalable Membrane Emulsification Process

2019

A scalable low-shear membrane emulsification process was used to produce microencapsulated Escherichia coli-phages in a solid oral dosage form. Uniform pH-responsive composite microparticles (mean size ~100 &micro

maha-suolitulehduslcsh:RS1-441Pharmaceutical Sciencebacteriophage therapy<i>E. coli</i>ArticleDosage formbakteriofagitRSlaw.inventionlääkesuunnittelulcsh:Pharmacy and materia medica03 medical and health sciencesConfocal microscopylawEscherichiaenterobakteeritMembrane emulsification030304 developmental biology0303 health sciencesChromatographybiologykalvot (tekniikka)030306 microbiologyChemistryenteric infectionsE. colibiology.organism_classificationControlled releaseIn vitroQR3. Good healthfagiterapiamikrorakenteetpH-triggered releaseCell cultureGastric acidmicroencapsulationcontrolled releaseEudragit S100Pharmaceutics
researchProduct